Since these tumors usually lack p53 abnormalities, the presence of these mutations can be associated with a poor prognosis across all cancer stages because p53 alterations are associated with an unfavorable subgroup of ovarian carcinoma (HGSOC). Here, TP53 is linked to cancer.